Travere Therapeutics (TVTX) Stock Chart & Stock Price History $17.26 +0.12 (+0.70%) (As of 10:39 AM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Travere Therapeutics Stock Price Performance 5 Day Performance-0.35%1 Month Performance-0.75%3 Month Performance+20.28%6 Month Performance+143.10%Year-To-Date Performance+91.99%1 Year Performance+108.96% Receive TVTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Travere Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Healthcare Takes A Big Step Forward With The Help of A.I. (Ad)To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still simple, proof-of-concept systems. For its next act, AI is going to help save lives. Already better than humans at a number of medical tasks, AI is ramping up to completely revolutionize healthcare.Click here to learn more about the booming eHealth industry - and see which microcap will be at the TVTX Stock Chart for Wednesday, December, 18, 2024 TVTX Chart by TradingView Travere Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/17/2024$17.50$17.14-2.06%$17.61$17.081.32 million shs$1.34 billion12/16/2024$17.32$17.50+1.04%$18.03$17.341.66 million shs$1.37 billion12/13/2024$17.91$17.32-3.29%$18.30$17.271.12 million shs$1.35 billion12/12/2024$18.68$17.91-4.12%$18.90$17.881.23 million shs$1.40 billion12/11/2024$18.75$18.68-0.37%$19.11$18.48792,544 shs$1.46 billion12/10/2024$18.77$18.75-0.11%$19.20$18.601.64 million shs$1.46 billion Get the Latest News and Ratings for TVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Travere Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/09/2024$19.22$18.77-2.34%$19.11$17.691.02 million shs$1.46 billion12/06/2024$19.41$19.22-0.98%$19.79$19.17995,722 shs$1.50 billion12/05/2024$19.37$19.41+0.21%$19.60$19.13561,781 shs$1.51 billion12/04/2024$19.38$19.37-0.05%$19.75$19.18717,938 shs$1.51 billion12/03/2024$19.57$19.38-0.97%$19.99$19.371.65 million shs$1.51 billion12/02/2024$18.81$19.57+4.04%$19.85$18.861.02 million shs$1.53 billion11/29/2024$18.70$18.81+0.59%$19.13$18.681.49 million shs$1.47 billion11/28/2024$18.70$18.70$19.23$18.69917,901 shs$1.46 billion11/27/2024$19.06$18.70-1.89%$19.23$18.69916,721 shs$1.46 billion11/26/2024$18.18$19.06+4.84%$19.12$18.191.75 million shs$1.49 billion11/25/2024$18.25$18.18-0.38%$18.73$18.14983,459 shs$1.42 billion11/22/2024$18.41$18.25-0.89%$18.93$18.031.10 million shs$1.42 billion11/21/2024$17.86$18.41+3.10%$18.64$17.89746,581 shs$1.44 billion11/20/2024$17.39$17.86+2.70%$17.87$17.05946,875 shs$1.39 billion11/19/2024$17.39$17.39$17.44$16.98975,172 shs$1.36 billion11/18/2024$17.72$17.39-1.86%$17.81$16.861.61 million shs$1.36 billion Related Companies TG Therapeutics Stock Chart Viking Therapeutics Stock Chart BridgeBio Pharma Stock Chart Crinetics Pharmaceuticals Stock Chart Krystal Biotech Stock Chart Arcellx Stock Chart ADMA Biologics Stock Chart Ultragenyx Pharmaceutical Stock Chart Apellis Pharmaceuticals Stock Chart Biohaven Stock Chart Receive TVTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Travere Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TVTX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Travere Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Travere Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
